IBRX peer analysis
ImmunityBio (IBRX) against its competitors: price, today's move, 1-year return and market value side by side.
IBRX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALLO Allogene Therapeutics | $1.06 | -2.75% | -6.76% | $357.58M |
| ATRA Atara Biotherapeutics | $7.96 | -4.90% | -25.95% | $79.90M |
| BNTX BioNTech | $87.00 | 1.33% | -15.33% | $22.15B |
| IMCR Immunocore | $30.99 | 9.12% | 0.65% | – |
| IMTX Immatics | $6.36 | 2.91% | -28.86% | – |
| IOVA Iovance | $8.05 | 3.95% | 344.75% | $3.65B |
| LEGN Legend Biotech | $23.47 | 4.13% | -26.59% | $4.55B |
| MRNA Moderna | $256.92 | 6.40% | 988.79% | $102.41B |
| NKTX Nkarta | $1.87 | 19.10% | -1.54% | – |
| VIR Vir Biotechnology | $12.32 | 11.81% | 131.30% | $2.11B |
| IBRX ImmunityBio | $8.59 | 7.29% | 299.07% | $9.09B |
- IBRX's peers: ALLO (Allogene Therapeutics), ATRA (Atara Biotherapeutics), BNTX (BioNTech), IMCR (Immunocore), IMTX (Immatics), IOVA (Iovance), LEGN (Legend Biotech), MRNA (Moderna).
Updated 2026-11-07 11:55 UTC